Decoy Therapeutics Inc. (DCOY)

NASDAQ

$5.20

$+2.38

(+92.97%)

Regular Market

Decoy Therapeutics Inc. (DCOY) Live Price Chart

Last updated: ⁦2026-09-22 13:31:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Decoy Therapeutics Inc. (DCOY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $5.20, with a market capitalisation of $1.82M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.18 to $16.92. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.82M
Open	$2.47
Day's High	$16.92
Day's Low	$2.18
Previous Close	$2.56
Volume	38.10M
Average Volume	255.76K
P/E Ratio	--
52-Week High	$16.92
52-Week Low	$2.18
Dividend Yield	--
Earnings Date	--

Decoy Therapeutics Inc. (DCOY) Stock Price Today

Decoy Therapeutics Inc. (DCOY) is currently trading at $5.20 as of 2026-09-22 13:14:45, up 103.05% ($2.64) from the previous close of $2.56

During today's regular trading session, DCOY has traded between $2.18 and $16.92, with a trading volume of 38.10M shares. The current price is near the lower end of today's range.

Decoy Therapeutics Inc. (DCOY) 7-Day Stock Price Change

Over the past seven days, Decoy Therapeutics Inc. (DCOY) moved from $2.67 to $5.20, representing a gain of 94.68% ($2.53).

The stock traded between $2.18 and $5.70 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 54.78 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

DCOY 52-Week Price Position

Position in Range: 20.5%

52W Low$2.18

52W High$16.92

DCOY is currently trading at $5.20, placing it 20.5% of the way from its 52-week low of $2.18 to its 52-week high of $16.92. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Decoy Therapeutics Inc. (DCOY)?

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Decoy Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	11
Exchange	NASDAQ
Company Website	https://www.decoytx.com

How to Buy Decoy Therapeutics Inc. (DCOY) Stock on MEXC

Eligible investors can buy real shares of Decoy Therapeutics Inc. (DCOY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DCOY and Place Your Order

Open the RealStocks trading page and search for DCOY. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Decoy Therapeutics Inc. (DCOY) stock price today?

Decoy Therapeutics Inc. (DCOY) is currently trading at $ 5.20, up 103.05% ($2.64) from the previous close of $ 2.56. Intraday prices update in real time during regular trading hours.

2.Is DCOY stock going up or down today?

As of 2026-09-22 13:14:45, DCOY is trading at $ 5.20, up 103.05% ($2.64) from its previous close of $ 2.56. The stock has traded between $ 2.18 and $ 16.92 during today’s regular session. Past price movements do not guarantee future results.

3.What is DCOY pre-market price?

As of 2026-09-22 13:14:45, DCOY is trading at $ 5.30 in pre-market trading, up 107.11% ($2.74) from the previous close of $ 2.56. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DCOY after-hours price?

As of 2026-09-22 13:14:45, DCOY is trading at $ 2.43 in after-hours trading, down 5.08% ($0.13) from the regular-session close of $ 2.56. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DCOY stock trading now?

DCOY trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DCOY sit relative to its 52-week high and low?

Over the past 52 weeks, DCOY has traded between a low of $ 2.18 and a high of $ 16.92. At $ 5.20, the stock is positioned 20.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Decoy Therapeutics Inc. in?

Decoy Therapeutics Inc. (DCOY) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Decoy Therapeutics Inc.'s market capitalisation and where is it listed?

Decoy Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 1.82M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DCOY valued in terms of P/E ratio and EPS?

DCOY trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -22.05. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Decoy Therapeutics Inc. pay a dividend?

Decoy Therapeutics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.